| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $24.2M | +167.0% |
| Cost of Revenue | $42.5M | +79.1% |
| Gross Profit | -$18.3M | -24.9% |
| R&D Expense | $7.3M | +99.7% |
| SG&A Expense | $18.7M | -8.0% |
| Operating Income | -$46.3M | -19.5% |
| Pre-tax Income | -$44.7M | -21.5% |
| Income Tax | $0 | — |
| Net Income | -$44.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $55.2M | +20.5% |
| Accounts Receivable | $5.6M | +341.1% |
| Inventory | $6.6M | +800.5% |
| Current Assets | $68.8M | +36.1% |
| Total Assets | $121.1M | +12.4% |
| Current Liabilities | $17.2M | +27.9% |
| Total Liabilities | $51.7M | +7.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.4M | -30.5% |
| Capital Expenditures | $3.2M | -81.7% |
| Investing Cash Flow | -$3.2M | +81.7% |
| Financing Cash Flow | $47.2M | +146.0% |
| Free Cash Flow | -$36.6M | +15.2% |
| -21.5% |
| EPS (Basic) | -$0.45 | -4.7% |
| EPS (Diluted) | -$0.45 | -4.7% |
| Stockholders' Equity |
| $69.5M |
| +16.2% |